67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01632605 (ClinicalTrials.gov)	November 2009	13/5/2012	The Vienna RAP Pilot Study	Rapamycin in Advanced Polycystic Kidney Disease Pilot Study	ADPKD	Drug: Sirolimus	Medical University of Vienna	NULL	Completed	18 Years	N/A	Both	8	N/A	Austria
2	NCT00920309 (ClinicalTrials.gov)	June 2009	12/6/2009	Rapamycinas Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarke ...	Rapamycin as Treatment for ADPKD: The Role of Biomarkers in Predicting a Response to Therapy	Autosomal Dominant Polycystic Kidney Disease	Drug: Rapamycin;Other: Standard of Care-Placebo	Yale University	NULL	Terminated	18 Years	70 Years	All	21	Phase 2/Phase 3	United States
3	EUCTR2007-006557-25-IT (EUCTR)	20/12/2007	18/12/2007	RAPAMYCIN FOR TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - RAPYD-STUDY	RAPAMYCIN FOR TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - RAPYD-STUDY	ADPKD type I MedDRA version: 9.1;Level: SOC;Classification code 10038359;Term: Renal and urinary dis ...	Trade Name: RAPAMUNE *100CPR RIV 1MG INN or Proposed INN: Sirolimus Product Name: Ramipril INN or Propos ...	AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE	NULL	Not Recruiting			Female: yes Male: yes			Italy
4	NCT00286156 (ClinicalTrials.gov)	October 2006	1/2/2006	Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease	Polycystic Kidney Diseases	Drug: Rapamune	The Cleveland Clinic	Wyeth is now a wholly owned subsidiary of Pfizer	Completed	18 Years	75 Years	All	30	Phase 1/Phase 2	United States

First Previous1Next Last